Literature DB >> 2807006

Long-term follow-up of potentiation of radiotherapy by cis-platinum in advanced cervical cancer.

L C Wong1, Y C Choo, D Choy, J S Sham, H K Ma.   

Abstract

Between January 1982 and January 1983 all patients with advanced cervical cancer were randomized into three groups: radiotherapy only (group I), radiotherapy plus weekly cis-platinum (group II), and radiation plus twice-weekly cis-platinum (group III). Better initial central control was observed in group III patients. Long-term survival was similar in the three groups. Potentiation of radiotherapy with cis-platinum failed to show any significant improvement in long-term survival.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2807006     DOI: 10.1016/0090-8258(89)90035-8

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  11 in total

1.  Chemotherapy and radiotherapy for locally advanced cervical cancer.

Authors:  C Williams
Journal:  BMJ       Date:  1999-05-01

2.  [How toxic and effective is simultaneous radiochemotherapy with hydroxyurea, 5-FU and cisplatin in cervix carcinoma?].

Authors:  H Lindner
Journal:  Strahlenther Onkol       Date:  1998-11       Impact factor: 3.621

3.  Chemoradiotherapy: the new standard care for invasive cervical cancer.

Authors:  P G Rose
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

Review 4.  Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis.

Authors: 
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

5.  Differing prognosis of cervical cancer patients with high risk of treatment failure after radical hysterectomy warrants trial treatment modification.

Authors:  Woo-Young Kim; Suk-Joon Chang; Ki-Hong Chang; Seung-Chul Yoo; Mison Chun; Hee-Sug Ryu
Journal:  J Gynecol Oncol       Date:  2009-03-31       Impact factor: 4.401

6.  Srinagarind Hospital experience in concurrent chemoradiation for 100 patients with stage IB2 to IVA uterine cervical cancer.

Authors:  Thumwadee Tangsiriwatthana; Bandit Chumworathayi; Pissamai Yuenyao; Sanguanchoke Luanratanakorn; Jeerichuda Pattamadilok
Journal:  Radiat Med       Date:  2007-12-25

Review 7.  Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials.

Authors: 
Journal:  J Clin Oncol       Date:  2008-11-10       Impact factor: 44.544

8.  [Result of concurrent chemoradiotherapy for cervical cancer at Radiation Oncology Service of University Hospital Joseph Ravoahangy Andrianavalona from 2007 to 2009].

Authors:  Ezra Niaina Randriamanovontsoa; Dera Andraina Ratsimandresy; Jean Marc Rakotonarivo; Auberlin Felantsoa Rakototiana; Harinirina Yoël Honora Rantomalala; Florine Rafaramino
Journal:  Pan Afr Med J       Date:  2014-11-18

Review 9.  Efficacy and toxicity of different concurrent chemoradiotherapy regimens in the treatment of advanced cervical cancer: A network meta-analysis.

Authors:  Zhan-Zhao Fu; Kun Li; Yong Peng; Yue Zheng; Li-Yan Cao; Yun-Jie Zhang; Yong-Mei Sun
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

10.  External Beam Therapy in a Four-Field Box Technique with Paclitaxel versus a Two-Field Technique with Cisplatin in Locally Advanced Carcinoma Cervix: A Phase II Monocentric Trial.

Authors:  Vijayakumar Narayanan; Bibek Bista; Samir Sharma
Journal:  ISRN Oncol       Date:  2012-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.